Contemporary Trends and Outcomes of Intravascular Lithotripsy in Percutaneous Coronary Intervention August 12, 2024 JACC: Cardiovascular Interventions
Marijuana Use and In-Hospital Outcomes After Percutaneous Coronary Intervention in Michigan, United States August 14, 2021 JACC: Cardiovascular Interventions
Safety of Contemporary Percutaneous Peripheral Arterial Interventions in the Elderly Insights From the BMC2 PVI (Blue Cross Blue Shield of Michigan Cardiovascular Consortium Peripheral Vascular Intervention) Registry June 1, 2011 JACC: Cardiovascular Interventions
Heterogeneity of Ankle-Brachial Indices in Patients Undergoing Revascularization for Critical Limb Ischemia November 27, 2017 JACC: Cardiovascular Interventions
Percutaneous Coronary Intervention Complications and Guide Catheter Size: Bigger is Not Better July 1, 2009 JACC: Cardiovascular Interventions
Retroperitoneal Hematoma After Percutaneous Coronary Intervention: Prevalence, Risk Factors, Management, Outcomes and Predictors of Mortality. A report From The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) Registry August 1, 2010 JACC: Cardiovascular Interventions
Contemporary use and effectiveness of N-Acetylcysteine in preventing contrast-induced nephropathy among patients undergoing percutaneous coronary intervention January 1, 2012 JACC: Cardiovascular Interventions
Impact of Automated Contrast Injector Systems on Contrast Use and Contrast Associated Complications in Patients Undergoing Percutaneous Coronary Interventions April 1, 2013 JACC: Cardiovascular Interventions
Trends in Contrast Volume Use and Incidence of Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention: Insights From Blue Cross Blue Shield of Michigan Cardiovascular Collaborative (BMC2) March 12, 2018 JACC: Cardiovascular Interventions
Primary and secondary vascular access site complications associated with percutaneous coronary intervention: insights from the BMC2 Registry November 25, 2019 JACC: Cardiovascular Interventions